265 related articles for article (PubMed ID: 19437324)
41. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
42. [Clinical and laboratory studies in seven patients with pre-B cell leukemia in children].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Satake A; Endo M; Shikano T; Konno M
Rinsho Ketsueki; 1989 Dec; 30(12):2173-7. PubMed ID: 2621799
[TBL] [Abstract][Full Text] [Related]
43. [Characterization of CD10 expression and its significance in minimal residual disease detection in childhood B-acute lymphoblastic leukemia].
Zhao HJ; Xu C; Chen J; Wu ZH; Xue HL; Tang JY; Pan C; Chen J; Li L; Gu LJ; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):350-4. PubMed ID: 12962560
[TBL] [Abstract][Full Text] [Related]
44. B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome.
Lundin C; Heldrup J; Ahlgren T; Olofsson T; Johansson B
Eur J Haematol; 2009 Jan; 82(1):46-53. PubMed ID: 19067745
[TBL] [Abstract][Full Text] [Related]
45. Prognostic irrelevance of CD34 expression in childhood B-precursor acute lymphoblastic leukemia.
Indolfi P; Casale F; Farzati B; D'Angelo V; De Sangro C; Rinaldi B
Haematologica; 1999 Jun; 84(6):567-8. PubMed ID: 10366809
[No Abstract] [Full Text] [Related]
46. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
[TBL] [Abstract][Full Text] [Related]
47. Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor.
Szinnai G; Cogliatti SB; Avoledo P; Dirnhofer S; Schmid U; Kühne T
Pediatr Blood Cancer; 2007 Dec; 49(7):1039-46. PubMed ID: 16572408
[TBL] [Abstract][Full Text] [Related]
48. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
[TBL] [Abstract][Full Text] [Related]
49. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
[TBL] [Abstract][Full Text] [Related]
50. Increased proportion of CD10-positive cells in a boy affected with common acute lymphoblastic leukemia in consolidation therapy.
Callea V; Sculli G; Comis M
Haematologica; 1997; 82(4):507. PubMed ID: 9299874
[No Abstract] [Full Text] [Related]
51. Expression and long-term prognostic value of CD34 in childhood and adult acute lymphoblastic leukemia.
Vanhaeke DR; Béné MC; Garand R; Faure GC
Leuk Lymphoma; 1995 Dec; 20(1-2):137-42. PubMed ID: 8750635
[TBL] [Abstract][Full Text] [Related]
52. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
[TBL] [Abstract][Full Text] [Related]
53. [Immunophenotyping characteristics of T-cell acute lymphoblastic leukemia].
Chen LJ; Li JY; Wu YJ; Yang H; Qian SX; Wu HX; Lu H; Xu W; Sheng RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):692-5. PubMed ID: 17708784
[TBL] [Abstract][Full Text] [Related]
54. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
55. Acute lymphoblastic leukemia.
Onciu M
Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
[TBL] [Abstract][Full Text] [Related]
56. Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.
Michaux K; Bergeron C; Gandemer V; Mechinaud F; Uyttebroeck A; Bertrand Y;
Pediatr Blood Cancer; 2016 Jul; 63(7):1214-21. PubMed ID: 27037853
[TBL] [Abstract][Full Text] [Related]
57. Immunophenotype of Acute Lymphoblastic Leukemia: The Experience of University Hospital Centre Casablanca - Morocco.
Addakiri S; Bencharef H; Jaddaoui S; Ait-Ichou K; Oukkache B
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702695
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study.
Borowitz MJ; Shuster JJ; Civin CI; Carroll AJ; Look AT; Behm FG; Land VJ; Pullen DJ; Crist WM
J Clin Oncol; 1990 Aug; 8(8):1389-98. PubMed ID: 1696310
[TBL] [Abstract][Full Text] [Related]
59. Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation-a case study.
Barbaric D; Wynne K; Aslanian S; Bond M; Reid GS
Leuk Res; 2005 Jun; 29(6):711-4. PubMed ID: 15863213
[TBL] [Abstract][Full Text] [Related]
60. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
